Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

Gunma University

Status: Completed

Conditions: Non-Small Cell Lung Cancer

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00698373

Molecular FMT imaging

Details and patient eligibility

About

L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional information for the preoperative diagnostic workup as compared with 18F-FDG PET. Tumor uptake of 18F-FMT was compared with several immunohistochemical markers including L-type amino acid transporter 1 (LAT1).

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with indeterminate pulmonary nodule suspicious of lung cancer

Exclusion criteria

• Patients with other malignancies and those who had received cancer treatment within the past 5 years were excluded.

Trial design

0 participants in 1 patient group

1

Description:

PET study